カテゴリ： MarketLine, イギリス, 企業調査

Rentokil Initial plc：企業の戦略・SWOT・財務分析

◆英語タイトル：Rentokil Initial plc - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4779
◆発行会社（調査会社）：MarketLine
◆発行日：2020年2月
◆ページ数：42
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：Business and Consumer Services
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Rentokil Initial plc – Strategy, SWOT and Corporate Finance Report
Summary

Rentokil Initial plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Rentokil Initial plc (Rentokil or ‘the company’) is a global provider of business services. The company offers services in the areas of pest control, hygiene, and work wear. Rentokil product portfolio comprises pest control products, air fresheners, sanitizers, feminine hygiene units, paper and linen towel dispensers and soap dispensers. The company provides pest control service, supply and maintenance of uniforms, protective equipments, interior landscaping, installation of interior and exterior plant displays, replica foliage services and ambient scenting. In addition it provides damp proofing, woodworm, property preservation and wood rot treatment, collection, disposal and recycling of hazardous waste. The company has operations across Europe, the Middle East and Africa, North America, and Asia Pacific. It is headquartered in Camberley, Surrey, the UK.

Scope

- Detailed information on Rentokil Initial plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Rentokil Initial plc in the form of a SWOT analysis
- An in-depth view of the business model of Rentokil Initial plc including a breakdown and examination of key business segments
- Intelligence on Rentokil Initial plc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Rentokil Initial plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Rentokil Initial plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Rentokil Initial plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Rentokil Initial plc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Rentokil Initial plc: Company Overview
Rentokil Initial plc: Overview and Key Facts
Rentokil Initial plc: Overview
Rentokil Initial plc: Key Facts
Rentokil Initial plc: Key Employees
Rentokil Initial plc: Key Employee Biographies
Rentokil Initial plc: Major Products and Services
Rentokil Initial plc: Company History
Rentokil Initial plc: Management Statement
Rentokil Initial plc: Locations and Subsidiaries
Rentokil Initial plc: Key Competitors
Rentokil Initial plc: Company Analysis
Rentokil Initial plc: Business Description
Rentokil Initial plc: SWOT Analysis
Rentokil Initial plc: SWOT Overview
Rentokil Initial plc: Strengths
Rentokil Initial plc: Weaknesses
Rentokil Initial plc: Opportunities
Rentokil Initial plc: Threats
Rentokil Initial plc: Corporate Financial Deals Activity
Rentokil Initial plc: Financial Deals Overview
Rentokil Initial plc: Targets and Partners
Rentokil Initial plc: Top Deals 2016 – 2020YTD*
Rentokil Initial plc: Advisors
Rentokil Initial plc: Top Legal Advisors
Rentokil Initial plc: Top Financial Advisors
Rentokil Initial plc: Mergers and Acquisitions
Rentokil Initial plc: Capital Raising
Rentokil Initial plc: Partnership
Rentokil Initial plc: Divestments
Rentokil Initial plc: Recent Developments
Rentokil Initial plc: News and Events Summary
Rentokil Initial plc: Corporate Governance
Rentokil Initial plc: Financial Deals
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Rentokil Initial plc: Key Facts
Table 2: Rentokil Initial plc: Key Employees
Table 3: Rentokil Initial plc: Company History
Table 4: Rentokil Initial plc: Locations and Subsidiaries
Table 5: Rentokil Initial plc: Key Competitors
Table 6: Rentokil Initial plc: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Rentokil Initial plc: M&A Activity by Geography (TTM*)
Table 8: Rentokil Initial plc: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 9: Rentokil Initial plc: M&A Average Deal Size - Value (US$m)
Table 10: Rentokil Initial plc: Targets and Partners
Table 11: Rentokil Initial plc: Top Deals 2016 - 2020YTD*
Table 12: Rentokil Initial plc: Legal Advisor Ranking by Value (US$m)
Table 13: Rentokil Initial plc: Financial Advisor Ranking by Value (US$m)
Table 14: Rentokil Initial plc: M&A Volume and Value Trend (2016 - YTD*2020)
Table 15: Rentokil Initial plc: M&A Activity by Geography (2016 - YTD*2020)
Table 16: Rentokil Initial plc: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 17: Rentokil Initial plc: Capital Raising by Deal Type (2016 - YTD*2020)
Table 18: Rentokil Initial plc: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 19: Rentokil Initial plc: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 20: Rentokil Initial plc: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 21: Rentokil Initial plc: Divestments by Geography (2016 - YTD*2020)
Table 22: Rentokil Initial plc: News and Events Summary
Table 23: Rentokil Initial plc: Corporate Governance
Table 24: Rentokil Initial plc: Financial Deals

★海外企業調査レポート[Rentokil Initial plc：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Ctrip.com International, Ltd.：企業のM&A・事業提携・投資動向
    Ctrip.com International, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ctrip.com International, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Amplifon SpA (AMP)：企業の財務・戦略的SWOT分析
    Amplifon SpA (AMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Coslight Technology International Group Ltd (1043)：企業の財務・戦略的SWOT分析
    Coslight Technology International Group Ltd (1043) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Okamoto Industries, Inc.：企業の戦略・SWOT・財務情報
    Okamoto Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Okamoto Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Pharmadax Inc (4191)：製薬・医療：M&Aディール及び事業提携情報
    Summary Pharmadax Inc (Pharmadax) is a drug development and generic specialty pharmaceutical company. The company develops modified release generics in various therapeutic segments. It offers products such as glyburide, quetiapine fumarate ER and metoprolol succinate ER. Pharmadax provides in the pr …
  • Can-Pack S.A.：企業の戦略・SWOT・財務情報
    Can-Pack S.A. - Strategy, SWOT and Corporate Finance Report Summary Can-Pack S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Linedata Services SA (LIN)：企業の財務・戦略的SWOT分析
    Linedata Services SA (LIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Key Energy Services Inc (KEGXD)：企業の財務・戦略的SWOT分析
    Key Energy Services Inc (KEGXD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Gruma, S.A.B. de C.V.：企業の戦略・SWOT・財務情報
    Gruma, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Gruma, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • CROS NT srl-製薬・医療分野：企業M&A・提携分析
    Summary CROS NT srl (CROS NT) is a contract research organization (CRO), which specializes in clinical data management, analysis, reporting and technologies. Its services include programming, analysis, medical writing, CROS academy training, methodology and clinical data management. Its outsourcing …
  • Fukoku Mutual Life Insurance Company
    Fukoku Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Fukoku Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • POSCO：企業のM&A・事業提携・投資動向
    POSCO - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's POSCO Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisin …
  • China Health Group Inc (8225)：企業の財務・戦略的SWOT分析
    China Health Group Inc (8225) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Keio Corporation (9008)：企業の財務・戦略的SWOT分析
    Keio Corporation (9008) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Getinge AB：企業の戦略・SWOT・財務情報
    Getinge AB - Strategy, SWOT and Corporate Finance Report Summary Getinge AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • 23andMe Inc-製薬・医療分野：企業M&A・提携分析
    Summary 23andMe Inc (23andMe) is a biotechnology research and information provider that offers tools for health and ancestry care. The company offers raw genetic data and ancestry-related genetic reports. It offers clinical development, research and development, ancestry services, commercialization …
  • Compal Electronics Inc (2324)：企業の財務・戦略的SWOT分析
    Summary Compal Electronics Inc (Compal) is a manufacturer of notebook based personal computers, liquid crystal display (LCD) products and smart devices. The company offers products which include display, communication, ODM and OEM, digital media, smart devices and automotive electronics. It also off …
  • Henkel AG & Co. KGaA：企業のM&A・事業提携・投資動向
    Henkel AG & Co. KGaA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Henkel AG & Co. KGaA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Novus Therapeutics Inc (NVUS)：製薬・医療：M&Aディール及び事業提携情報
    Summary Novus Therapeutics Inc (Tokai Pharma), formerly Tokai Pharmaceuticals Inc is a pharmaceutical company that develops products for ear, nose and throat. The company’s lead products is a nasally-administer, combination drug product and eustachian tube dysfunction, among others. Its galeterone i …
  • Broadridge Financial Solutions, Inc.：企業の戦略・SWOT・財務分析
    Broadridge Financial Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Broadridge Financial Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆